From 512b9879be89b088b59e50918d990499c140bea3 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Mon, 16 Mar 2026 14:07:31 +0000 Subject: [PATCH] extract: 2025-12-23-cms-balance-model-glp1-obesity-coverage Pentagon-Agent: Ganymede --- ...t cost impact inflationary through 2035.md | 6 ++++ ...rofits from health rather than sickness.md | 6 ++++ ...rics but only 14 percent bear full risk.md | 6 ++++ ...s-balance-model-glp1-obesity-coverage.json | 28 +++++++++++++++++++ ...cms-balance-model-glp1-obesity-coverage.md | 18 +++++++++++- 5 files changed, 63 insertions(+), 1 deletion(-) create mode 100644 inbox/archive/.extraction-debug/2025-12-23-cms-balance-model-glp1-obesity-coverage.json diff --git a/domains/health/GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md b/domains/health/GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md index dc7e4b78..ff0765e3 100644 --- a/domains/health/GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md +++ b/domains/health/GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md @@ -41,6 +41,12 @@ MA plans' near-universal prior authorization creates administrative friction tha MASH/NASH is projected to become the leading cause of liver transplantation. GLP-1s now demonstrate efficacy across three major organ systems (cardiovascular, renal, hepatic), which strengthens the multi-indication economic case for chronic use. The 62.9% MASH resolution rate suggests GLP-1s could prevent progression to late-stage liver disease and transplantation, though the Value in Health Medicare study showed only $28M MASH savings—surprisingly small given clinical magnitude, likely because MASH progression to transplant takes decades and falls outside typical budget scoring windows. + +### Additional Evidence (extend) +*Source: [[2025-12-23-cms-balance-model-glp1-obesity-coverage]] | Added: 2026-03-16* + +The BALANCE Model directly addresses the chronic use inflation problem by requiring lifestyle interventions alongside medication. If lifestyle supports can sustain metabolic benefits after medication discontinuation, the model could demonstrate a pathway to positive net cost impact. The 6-year test window (through 2031) will provide empirical data on whether combined intervention changes the chronic use economics. + --- Relevant Notes: diff --git a/domains/health/the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md b/domains/health/the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md index 2db79d2d..5e923430 100644 --- a/domains/health/the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md +++ b/domains/health/the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md @@ -303,6 +303,12 @@ C-SNP growth of 71% in one year shows MA plans are rapidly building chronic dise PACE is the strongest counter-evidence to attractor state inevitability. Operating since the 1970s with full capitation for the most complex Medicare/Medicaid patients (avg 76 years, 7+ chronic conditions, nursing-home eligible), PACE has achieved only 0.13% Medicare penetration (80,815 enrollees out of 67M eligible) as of 2025. Seven structural barriers prevent scaling despite clinical success: capital requirements, awareness deficits, insufficient enrollee concentration, geographic concentration in 3 states, dual-eligibility requirements, state-by-state regulatory complexity, and single-state operator structures. The 50-year timeline proves that model superiority does not guarantee market adoption—structural barriers can indefinitely prevent the attractor state even when the model demonstrably works. + +### Additional Evidence (confirm) +*Source: [[2025-12-23-cms-balance-model-glp1-obesity-coverage]] | Added: 2026-03-16* + +The BALANCE Model is the first federal policy explicitly designed to test the prevention-first attractor state thesis. By combining GLP-1 access with lifestyle supports and adjusting capitated payment rates, CMS is creating the aligned payment structure that the attractor state requires. The model's success or failure will provide the strongest empirical test yet of whether prevention-first systems can be profitable under risk-bearing arrangements. + --- Relevant Notes: diff --git a/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md b/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md index 44683c0c..480ec592 100644 --- a/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md +++ b/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md @@ -41,6 +41,12 @@ Medicare Advantage plans bearing full capitated risk increased GLP-1 prior autho PACE represents the 100% risk endpoint—full capitation for all medical, social, and psychiatric needs, entirely replacing Medicare and Medicaid cards. Yet even at full risk with proven outcomes for the highest-cost patients, PACE serves only 0.13% of Medicare eligibles after 50 years. This suggests the stall point is not just at the payment boundary (partial vs full risk) but at the scaling boundary—capital, awareness, regulatory, and operational barriers prevent even successful full-risk models from achieving market penetration. The gap between 14% bearing full risk and PACE's 0.13% penetration indicates that moving from partial to full risk is necessary but insufficient for VBC transformation. + +### Additional Evidence (extend) +*Source: [[2025-12-23-cms-balance-model-glp1-obesity-coverage]] | Added: 2026-03-16* + +The BALANCE Model moves payment toward genuine risk by adjusting capitated rates for obesity and increasing government reinsurance for participating MA plans. This creates a direct financial incentive mechanism where plans profit from preventing obesity-related complications rather than just managing them. The model explicitly tests whether combining medication access with lifestyle supports under risk-bearing arrangements can shift the payment boundary. + --- Relevant Notes: diff --git a/inbox/archive/.extraction-debug/2025-12-23-cms-balance-model-glp1-obesity-coverage.json b/inbox/archive/.extraction-debug/2025-12-23-cms-balance-model-glp1-obesity-coverage.json new file mode 100644 index 00000000..60d21778 --- /dev/null +++ b/inbox/archive/.extraction-debug/2025-12-23-cms-balance-model-glp1-obesity-coverage.json @@ -0,0 +1,28 @@ +{ + "rejected_claims": [ + { + "filename": "cms-balance-model-tests-glp-1-plus-lifestyle-intervention-under-risk-bearing-payment.md", + "issues": [ + "missing_attribution_extractor" + ] + } + ], + "validation_stats": { + "total": 1, + "kept": 0, + "fixed": 5, + "rejected": 1, + "fixes_applied": [ + "cms-balance-model-tests-glp-1-plus-lifestyle-intervention-under-risk-bearing-payment.md:set_created:2026-03-16", + "cms-balance-model-tests-glp-1-plus-lifestyle-intervention-under-risk-bearing-payment.md:stripped_wiki_link:the healthcare attractor state is a prevention-first system ", + "cms-balance-model-tests-glp-1-plus-lifestyle-intervention-under-risk-bearing-payment.md:stripped_wiki_link:GLP-1 receptor agonists are the largest therapeutic category", + "cms-balance-model-tests-glp-1-plus-lifestyle-intervention-under-risk-bearing-payment.md:stripped_wiki_link:glp-1-persistence-drops-to-15-percent-at-two-years-for-non-d", + "cms-balance-model-tests-glp-1-plus-lifestyle-intervention-under-risk-bearing-payment.md:stripped_wiki_link:value-based care transitions stall at the payment boundary b" + ], + "rejections": [ + "cms-balance-model-tests-glp-1-plus-lifestyle-intervention-under-risk-bearing-payment.md:missing_attribution_extractor" + ] + }, + "model": "anthropic/claude-sonnet-4.5", + "date": "2026-03-16" +} \ No newline at end of file diff --git a/inbox/archive/2025-12-23-cms-balance-model-glp1-obesity-coverage.md b/inbox/archive/2025-12-23-cms-balance-model-glp1-obesity-coverage.md index e346c64c..46c6868e 100644 --- a/inbox/archive/2025-12-23-cms-balance-model-glp1-obesity-coverage.md +++ b/inbox/archive/2025-12-23-cms-balance-model-glp1-obesity-coverage.md @@ -7,9 +7,13 @@ date: 2025-12-23 domain: health secondary_domains: [internet-finance] format: policy -status: unprocessed +status: enrichment priority: high tags: [glp-1, cms, balance-model, medicare, medicaid, value-based-care, payment-model] +processed_by: vida +processed_date: 2026-03-16 +enrichments_applied: ["value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md", "GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md", "the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md"] +extraction_model: "anthropic/claude-sonnet-4.5" --- ## Content @@ -50,3 +54,15 @@ CMS announced the Better Approaches to Lifestyle and Nutrition for Comprehensive PRIMARY CONNECTION: [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness]] WHY ARCHIVED: First explicit federal test of the GLP-1 + VBC thesis — if it demonstrates net savings under risk-bearing, it validates the prevention-first attractor state; if it fails, it complicates it EXTRACTION HINT: Focus on the structural design (medication + lifestyle + payment adjustment) as a test of the attractor state thesis, not just as drug coverage policy + + +## Key Facts +- CMS announced the BALANCE Model on December 23, 2025 +- Manufacturer RFA due January 8, 2026 +- Medicaid participation begins May 2026 +- Medicare Part D bridge demonstration begins July 2026 +- Full Medicare Part D participation begins January 2027 +- Model testing concludes December 2031 +- CMS negotiates pricing centrally on behalf of participating plans +- Model includes adjustment of capitated payment rates for obesity +- Model includes increased government reinsurance for participating plans